Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Barry
Contact Barry, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Expanded Access use of Intravenous Gene Transfer with AAV9-GLB1 in a Juvenile GM1 Gangliosidosis Participant
XJ is named a co-inventor on a patent application pertaining to use of pentasaccharide biomarkers in GM1 gangliosidosis. ALG, DRM, HLG-E and MSE are beneficiaries of a prior licensing agreement with Sio Gene Therapies (New York, New York). DRM and MSE are shareholders in Lysogene (Neuilly-sur-Seine, France).
The Speak Foundation Announces 2026 LGMD Scientific Summit
FREE Breaking News Alerts from StreetInsider.com! E-mail Address StreetInsider.com Top Tickers, 7/27/2026 1. NVDA 2. BSP 3. HCA 4. ITG 5. CHTR 6. AZN 7. LIME 8. BKR 9. VZ 10.
Muscular Dystrophy Association Announces $100,000 Investment to Advance LGMD Care at Leading MDA Care Centers with BridgeBio Original
New York, May 12, 2026 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced a $100,000 investment by BridgeBio to strengthen multidisciplinary care for people living with limb-girdle muscular dystrophy (LGMD).
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Barry
Contact Barry, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack